Key Drivers
- High gross margin
- Liquidity improving
- Mild downtrend
AIAI Summary
Phreesia appears to be shifting from growth-at-all-costs to a liquidity- and profitability-first profile—meaning investors should now weight the upside of recurring SaaS expansion against the concrete near-term tests of sustaining opex discipline, converting ProviderConnect into measurable ARR, and managing executive-level legal/governance risk.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •High gross margin
- •Liquidity improving
PHR combines strong unit economics (68% gross margin) and improving liquidity/deleveraging with a recent quarterly profit, but legacy operating losses, large intangibles/negative retained earnings and a ~32.5x EV/EBITDA make valuation and balance‑sheet quality key risks.
Valuation: Recent profitability is encouraging, but the ~32.5x EV/EBITDA and historical accumulated losses suggest the stock is richly priced and warrants caution.
Price Behavior
Key Price Behavior Insights:
- •Mild downtrend
- •Holding just above average
- •Bounces from lows
PHR is mildly down over the last month (~‑6.7%) but stabilizing just above the last month average near $11.81 with recent bounces from about $10.97—downside risk remains until a clear break above $12.60–$12.70.
Small recovery off lows around $10.97 on 2026-03-13
Sentiment & News
Key News Insights:
- •Liquidity boost
- •Board refresh
- •Product launch
Phreesia secured a $275M senior secured revolver refinancing its bridge loan, refreshed its board, launched ProviderConnect and collected industry awards while its stock rose 5.1% amid mixed earnings-estimate revisions.
The new credit facility and leadership changes shore up near-term liquidity and governance, supporting continued stock momentum but mixed analyst revisions could cap upside
Similar Companies in Healthcare
Other companies in the same sector with AI ratings